Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Van Hout

Showing results (51-60 of 115) with videos related to

Pageof 12
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|December 18, 1998
[Economic evaluation of cardiology; background and application]B A van Hout, E S Goes, E W Grijseels, et al.
Clinical Therapeutics|May 17, 2003
A pharmacoeconomic comparison of the efficacy and costs of pantoprazole and omeprazole for the treatment of peptic ulcer or gastroesophageal reflux disease in The NetherlandsBen A van Hout, Rogier M Klok, Jacobus R B J Brouwers, et al.
Anti-Cancer Drugs|May 18, 1999
An economic evaluation of Tomudex (raltitrexed) and 5-fluorouracil plus leucovorin in advanced colorectal cancerM G Groener, B M van Ineveld, G Byttebier, et al.
Plos One|July 28, 2010
Quantifying cost-effectiveness of controlling nosocomial spread of antibiotic-resistant bacteria: the case of MRSAMarjan W M Wassenberg, G Ardine de Wit, Ben A van Hout, et al.
American Heart Journal|April 16, 1998
Use of abciximab in interventional cardiologyN Chronos, A Vahanian, A Betriu, et al.
European Heart Journal|May 23, 1998
Use of abciximab in interventional cardiologyN Chronos, A Vahanian, A Betriu, et al.
Health Policy (Amsterdam, Netherlands)|March 18, 2000
Diabetes nephropathy in the Netherlands: a cost effectiveness analysis of national clinical guidelinesN van Os, L W Niessen, H J Bilo, et al.
Pharmacoeconomics|July 16, 2008
Modelling approaches: the case of schizophreniaBart M S Heeg, Joep Damen, Erik Buskens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 4, 2009
Economic evaluation of zoledronic acid for the prevention of osteoporotic fractures in postmenopausal women with early-stage breast cancer receiving aromatase inhibitors in the UKJ F S Logman, B M S Heeg, M F Botteman, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 23, 1998
Hip fracture prediction in elderly men and women: validation in the Rotterdam studyC E De Laet, B A Van Hout, H Burger, et al.
Pageof 12

Showing results (51-60 of 115) with videos related to

Sort By:
Pageof 12
Nederlands Tijdschrift Voor Geneeskunde|December 18, 1998
[Economic evaluation of cardiology; background and application]B A van Hout, E S Goes, E W Grijseels, et al.
Clinical Therapeutics|May 17, 2003
A pharmacoeconomic comparison of the efficacy and costs of pantoprazole and omeprazole for the treatment of peptic ulcer or gastroesophageal reflux disease in The NetherlandsBen A van Hout, Rogier M Klok, Jacobus R B J Brouwers, et al.
Anti-Cancer Drugs|May 18, 1999
An economic evaluation of Tomudex (raltitrexed) and 5-fluorouracil plus leucovorin in advanced colorectal cancerM G Groener, B M van Ineveld, G Byttebier, et al.
Plos One|July 28, 2010
Quantifying cost-effectiveness of controlling nosocomial spread of antibiotic-resistant bacteria: the case of MRSAMarjan W M Wassenberg, G Ardine de Wit, Ben A van Hout, et al.
American Heart Journal|April 16, 1998
Use of abciximab in interventional cardiologyN Chronos, A Vahanian, A Betriu, et al.
European Heart Journal|May 23, 1998
Use of abciximab in interventional cardiologyN Chronos, A Vahanian, A Betriu, et al.
Health Policy (Amsterdam, Netherlands)|March 18, 2000
Diabetes nephropathy in the Netherlands: a cost effectiveness analysis of national clinical guidelinesN van Os, L W Niessen, H J Bilo, et al.
Pharmacoeconomics|July 16, 2008
Modelling approaches: the case of schizophreniaBart M S Heeg, Joep Damen, Erik Buskens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 4, 2009
Economic evaluation of zoledronic acid for the prevention of osteoporotic fractures in postmenopausal women with early-stage breast cancer receiving aromatase inhibitors in the UKJ F S Logman, B M S Heeg, M F Botteman, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 23, 1998
Hip fracture prediction in elderly men and women: validation in the Rotterdam studyC E De Laet, B A Van Hout, H Burger, et al.
Pageof 12